Raymond Stevens, Structure Therapeutics CEO, joins ‘Fast Money’ to talk its oral GLP-1 offerings.
Source link
Trending
- His dad’s illness drew Andrew Wiggins away from basketball. Now the Warrior is rediscovering his joy
- I interviewed leading longevity experts in 2024: 3 things I learned
- Most interesting NBA awards: An unknown Rookie of the Year? Wide-open Most Improved race?
- Why these 4 Americans moved abroad and don’t plan on coming back
- Cheap small-cap stocks for your stocking heading into 2025
- Nvidia sees ‘remarkable’ influx of retail investor dollars as traders flock to AI darling
- AI, crypto top tech stocks: AppLovin, MicroStrategy, Palantir, Nvidia
- From Fighters to Policemen in a Post-Assad Damascus
Structure CEO on the competitive landscape for oral GLP-1 drugs
